Evaluating the Effect of Non-cellular Bioactive Glass-Containing Scaffolds on Osteogenesis and Angiogenesis in in vivo Animal Bone Defect Models

Abstract

The use of bone scaffolds to replace injured or diseased bone has many advantages over the currently used autologous and allogeneic options in clinical practice. This systematic review evaluates the current evidence for non-cellular scaffolds containing bioactive glass on osteogenesis and angiogenesis in animal bone defect models. Studies that reported results of osteogenesis via micro-CT and results of angiogenesis via Microfil perfusion or immunohistochemistry were included in the review. A literature search of PubMed, EMBASE and Scopus was carried out in November 2019 from which nine studies met the inclusion and exclusion criteria. Despite the significant heterogeneity in the composition of the scaffolds used in each study, it could be concluded that scaffolds containing bioactive glass improve bone regeneration in these models, both by osteogenic and angiogenic measures. Incorporation of additional elements into the glass network, using additives, and using biochemical factors generally had a beneficial effect. Comparing the different compositions of non-cellular bioactive glass containing scaffolds is however difficult due to the heterogeneity in bioactive glass compositions, fabrication methods and biochemical additives used.

Silicified collagen scaffold induces semaphorin 3A secretion by sensory nerves to improve in-situ bone regeneration

“…Silicon has also been considered a potent element that promotes angiogenesis at therapeutic doses [ 35 ]. Release of silicic acid is considered to be the major factor in promoting osteogenesis of bioceramic materials [ 36 ]. Silicic acid molecules that enter cells act as signals for upregulation of genes that generate cell cycle regulator proteins and growth factors [ 16 , 37 ].…”

In vivo prevascularization strategy enhances neovascularization of β-tricalcium phosphate scaffolds in bone regeneration

“…One leading obstacle for most tissue-engineered scaffolds is the lack of sufficient vascularization within the scaffold [ 6 ]. As slow ingrowth of the host's vasculature into the center of bone grafts hinders further bone consolidation [ 7 ], some have concluded that neovascularization is vital to bone regeneration [ 8 ]. New strategies are needed to overcome this roadblock and effectively achieve vascularized tissue-engineered bone grafts.…”

Injectable bioactive glass/sodium alginate hydrogel with immunomodulatory and angiogenic properties for enhanced tendon healing

“…Heterotopic ossification refers to the formation of pathological bone in soft tissue and can occur with soft tissue injury, including tendon injury. 48 Given that BG has been reported to promote osteogenesis, 49 it may, therefore, increase the risk of heterotopic ossification. To assess whether BG/SA hydrogel treatment induced heterotopic ossification, we performed IHC staining of RUNX2 and OCN (early and late osteolineage markers, indicating mineralization sites).…”